3649 results for «369»

Filter By

3649 results

Acute complications during distal left main PCI - Part 2

22 May 2025 – From EuroPCR 2025

This session focuses on acute complications encountered during distal left main PCI. Review real-world challenging cases involving multiple unexpected complications, device retrieval techniques, fractured rota burr management during rota-tripsy, and strategies to navigate complex procedural challenges.

Acute complications during distal left main PCI - Part 2

The role of DCB in non-left main true bifurcations

22 May 2025 – From EuroPCR 2025

This session offers a detailed exploration of drug-coated balloon (DCB) use in non-left main true bifurcation lesions. Learn to define suitable lesion characteristics for provisional stenting, understand stepwise procedural strategies minimizing implanted material, and appreciate the role of intravascular imaging in assessing bifurcation complexity and optimizing...

The role of DCB in non-left main true bifurcations

Optimal use of cardiac imaging to plan and guide transcatheter LAA closure

22 May 2025 – From EuroPCR 2025

Optimize left atrial appendage (LAA) closure outcomes through expert use of cardiac imaging. This session details the role of various imaging modalities in pre-procedural planning, intraprocedural guidance, and post-procedural assessment. Gain practical insights on transesophageal echocardiography, computed tomography, intracardiac echocardiography, and their integration to enhance procedural...

Optimal use of cardiac imaging to plan and guide transcatheter LAA closure

TAVI outcomes

22 May 2025 – From EuroPCR 2025

Examine contemporary outcomes of transcatheter aortic valve implantation (TAVI) across diverse patient populations and device generations. This session presents data on severe aortic stenosis stratified by resting gradient, comparisons between bicuspid and tricuspid valve stenosis, and clinical results of intra-annular versus supra-annular devices, including two-year outcomes...

TAVI outcomes

Challenging session in calcified lesions

22 May 2025 – From EuroPCR 2025

Engage with a challenging session focused on complex calcified lesion interventions. Topics include innovative triple burr techniques, OCT insights into resistant lesions, volume reduction strategies, eccentric calcium management, and IVUS-guided left main calcified lesion treatment, highlighting practical approaches to difficult cases.

Challenging session in calcified lesions

Coronary physiology: FFR and beyond

22 May 2025 – From EuroPCR 2025

Advance your understanding of coronary physiology with a focus on fractional flow reserve (FFR) and beyond. This session covers randomized trials comparing physiology-guided treatment to standard care in ANOCA, graft patency related to quantitative flow ratio, impacts of microvascular dysfunction on patient outcomes, and prognostic value...

Coronary physiology: FFR and beyond

Leaflet modification to prevent coronary obstruction during TAVI

22 May 2025 – From EuroPCR 2025

This session addresses advanced leaflet modification techniques to prevent coronary obstruction during TAVI. Learn from detailed cases involving valve-in-valve interventions, treatment of failed stentless valves, homograft management, and dedicated devices for leaflet modification prior to valve-in-valve and valve-in-valve-in-valve procedures.

Leaflet modification to prevent coronary obstruction during TAVI

All you need to know on aorto iliac disease during TAVI: from access to complications management

22 May 2025 – From EuroPCR 2025

Gain expertise in managing aorto-iliac disease during TAVI procedures, from access planning to complication management. This session covers key imaging techniques, decision-making regarding stenting and lesion modification, approaches to access-related complications, and criteria for involving vascular surgeons, ensuring procedural safety and success.

All you need to know on aorto iliac disease during TAVI: from access to complications management

BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

07 Nov 2022

Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.

This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...

Nicola Ryan

Author

Nicola Ryan
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial
Didn’t find what you were looking for?